Literature DB >> 21979414

Anti-T lymphocyte globulin (ATG) induces generation of regulatory T cells, at least part of them express activated CD44.

Orly Shimony1, Arnon Nagler, Yechiel N Gellman, Efrat Refaeli, Nir Rosenblum, Lora Eshkar-Sebban, Ronit Yerushalmi, Avichai Shimoni, Simon D Lytton, Anfisa Stanevsky, Reuven Or, David Naor.   

Abstract

We show here that the anti-T lymphocyte immunoglobulin (ATG) can induce Treg cells following 24-h incubation in human peripheral blood mononuclear cells (PBMCs). The ATG-induced Treg cells express known cell surface markers (e.g., CD25, FoxP3) and suppress the proliferation of autologous responder PBMCs, stimulated with allogeneic PBMCs, when added into the mixed lymphocyte culture (MLC) at zero time point or 48 h later. We expanded the characteristics of the ATG-induced human Treg cells by showing that they express a novel biomarker designated "activated CD44". ATG-induced Treg cells retain their suppressor function after freezing and thawing or irradiation. Suppression of MLC by ATG-induced Treg cells is consistently seen when the Treg cells and the responder cells were derived from the same donor, but not when they derived from different donors. Finally, patients undergoing stem cell transplantation and conditioned with ATG generate in vivo Treg cells that suppress MLC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979414     DOI: 10.1007/s10875-011-9599-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  19 in total

Review 1.  Th17 and regulatory T cells in mediating and restraining inflammation.

Authors:  Dan R Littman; Alexander Y Rudensky
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis.

Authors:  Booki Min; Angela Thornton; Stephan M Caucheteux; Souheil-Antoine Younes; Keunhee Oh; Jane Hu-Li; William E Paul
Journal:  Eur J Immunol       Date:  2007-07       Impact factor: 5.532

3.  Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro.

Authors:  Xingmin Feng; Sachiko Kajigaya; Elena E Solomou; Keyvan Keyvanfar; Xiuli Xu; Nalini Raghavachari; Peter J Munson; Thomas M Herndon; Jichun Chen; Neal S Young
Journal:  Blood       Date:  2008-02-04       Impact factor: 22.113

Review 4.  IL-17 and Th17 Cells.

Authors:  Thomas Korn; Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

5.  ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells.

Authors:  Raewyn Broady; Jie Yu; Megan K Levings
Journal:  Blood       Date:  2009-10-12       Impact factor: 22.113

6.  Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44.

Authors:  Mihail Firan; Sohita Dhillon; Pila Estess; Mark H Siegelman
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

7.  Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells.

Authors:  Paul L Bollyky; James D Lord; Susan A Masewicz; Stephen P Evanko; Jane H Buckner; Thomas N Wight; Gerald T Nepom
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

8.  Anti-thymocyte globulin (ATG) prevents autoimmune encephalomyelitis by expanding myelin antigen-specific Foxp3+ regulatory T cells.

Authors:  Denise T Chung; Thomas Korn; Julie Richard; Melanie Ruzek; Adam P Kohm; Stephen Miller; Sharon Nahill; Mohamed Oukka
Journal:  Int Immunol       Date:  2007-08-13       Impact factor: 4.823

Review 9.  Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond.

Authors:  M Mohty
Journal:  Leukemia       Date:  2007-04-05       Impact factor: 11.528

10.  CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells.

Authors:  Tie Liu; Lynn Soong; Gang Liu; Rolf König; Ashok K Chopra
Journal:  Biol Direct       Date:  2009-10-23       Impact factor: 4.540

View more
  22 in total

1.  Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation.

Authors:  C Wolschke; T Zabelina; F Ayuk; H Alchalby; J Berger; E Klyuchnikov; U-M Pein; S Schumacher; G Amtsfeld; R Adjallé; F Wortmann; H Lellek; A Randenborgh; A Zander; N Kröger
Journal:  Bone Marrow Transplant       Date:  2013-09-16       Impact factor: 5.483

Review 2.  Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Authors:  Frédéric Baron; Mohamad Mohty; Didier Blaise; Gérard Socié; Myriam Labopin; Jordi Esteve; Fabio Ciceri; Sebastian Giebel; Norbert Claude Gorin; Bipin N Savani; Christoph Schmid; Arnon Nagler
Journal:  Haematologica       Date:  2016-12-07       Impact factor: 9.941

3.  Regulatory T Cells for the Induction of Transplantation Tolerance.

Authors:  Weitao Que; Xiao-Kang Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.

Authors:  Shigeo Fuji; Takero Shindo
Journal:  Stem Cell Investig       Date:  2016-10-31

Review 5.  Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly.

Authors:  Coco de Koning; Rick Admiraal; Stefan Nierkens; Jaap Jan Boelens
Journal:  Stem Cell Investig       Date:  2017-05-16

Review 6.  Pharmacologic targeting of regulatory T cells for solid organ transplantation: current and future prospects.

Authors:  Kassem Safa; Sindhu Chandran; David Wojciechowski
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

Review 7.  Impact of Immune-Modulatory Drugs on Regulatory T Cell.

Authors:  Akiko Furukawa; Steven A Wisel; Qizhi Tang
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939

8.  Tolerogenic therapies in transplantation.

Authors:  Eugenia K Page; Wasim A Dar; Stuart J Knechtle
Journal:  Front Immunol       Date:  2012-07-18       Impact factor: 7.561

9.  Anti-thymocyte globulin induces neoangiogenesis and preserves cardiac function after experimental myocardial infarction.

Authors:  Michael Lichtenauer; Michael Mildner; Gregor Werba; Lucian Beer; Konrad Hoetzenecker; Andrea Baumgartner; Matthias Hasun; Stefanie Nickl; Andreas Mitterbauer; Matthias Zimmermann; Mariann Gyöngyösi; Bruno Karl Podesser; Walter Klepetko; Hendrik Jan Ankersmit
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

Review 10.  Regulatory T cells in allogeneic stem cell transplantation.

Authors:  Maria Michael; Avichai Shimoni; Arnon Nagler
Journal:  Clin Dev Immunol       Date:  2013-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.